# Single Dose Mass Balance Study With C14 - Labeled AAI101 in Healthy Male Volunteers

> **NCT03775668** · PHASE1 · COMPLETED · sponsor: **Allecra** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 1 µCi of 14C-AAI101 + 500 mg AAI101

## Key facts

- **NCT ID:** NCT03775668
- **Lead sponsor:** Allecra
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-27
- **Primary completion:** 2018-12-05
- **Final completion:** 2019-01-31
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2019-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03775668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03775668, "Single Dose Mass Balance Study With C14 - Labeled AAI101 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03775668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*